US Senate Panel to Weigh Novo Nordisk Subpoena Over Ozempic, Wegovy Prices

June 12, 2024

(Reuters) – The U.S. Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S. prices for weight loss drugs Ozempic and Wegovy, which are far higher than those in other countries. (Read More)